Alison Farley

Title: Alison Farley: Innovator in Haemopoietin Receptor and Cytokine Signaling

Introduction

Alison Farley is a distinguished inventor based in Port Fairy, Australia. She has made significant contributions to the field of medical research, particularly in the development of novel receptors and their applications in therapeutic contexts. With a total of two patents to her name, her work has the potential to impact various aspects of cell biology and medicine.

Latest Patents

Alison Farley's latest patents include the invention of a haemopoietin receptor and the genetic sequence encoding it. This invention relates to a novel haemopoietin receptor or its derivatives, which interact with cytokine ligands to facilitate the proliferation, differentiation, and survival of various cell types. The receptor and its derivatives, along with the genetic sequences, are valuable for developing a range of agonists, antagonists, therapeutics, and diagnostic reagents based on ligand-receptor interactions.

Another significant patent involves screening methods using SOCS box-containing peptides. This invention focuses on amino acid sequences derived from SOCS proteins that can interact with intracellular molecules. The nucleic acid molecules encoding these sequences are instrumental in modulating the degradation of proteinaceous molecules, including SOCS proteins. This mechanism provides a way to influence cytokine signaling by regulating the degradation of activated signal transduction molecules or their negative regulators.

Career Highlights

Throughout her career, Alison has worked with notable organizations, including Zenyth Operations Pty. Ltd. and the Walter and Eliza Hall Institute of Medical Research. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Alison has collaborated with several professionals, including Tracy Ann Willson and Nicos Anthony Nicola. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Alison Farley is a remarkable inventor whose work in haemopoietin receptors and cytokine signaling has the potential to advance medical research and therapeutic development. Her contributions reflect a commitment to innovation and collaboration in the scientific community.